The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Oral Session

Oral Session 2-7D Indolent Lymphoma: Novel Therapy

Sat. Oct 12, 2019 4:00 PM - 5:00 PM No.7 (Tokyo International Forum, 5F Hall D5)

Chair: Wataru Munakata (Department of Hematology, National Cancer Center Hospital)

[OS2-7D-6] Safety profile of bendamustine in combination with obinutuzumab or rituximab for follicular lymphoma

Keiichi Uchida1, Harumi Kato1, Masamitsu Yanada1, Hirofumi Taji1, Toko Saito1, Shoichi Kato2, Yasushi Yatabe2, Kazuhito Yamamoto1 (1.Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, 2.Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password